Dr Jeannine Avis Clark, MD | |
6915 Laurel Bowie Road, Suite 301, Bowie, MD 20715 | |
(301) 249-8838 | |
(301) 249-5334 |
Full Name | Dr Jeannine Avis Clark |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 6915 Laurel Bowie Road, Bowie, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457389892 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D0043862 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeannine Avis Clark, MD 6915 Laurel Bowie Road, Suite 301, Bowie, MD 20715 Ph: (301) 249-8838 | Dr Jeannine Avis Clark, MD 6915 Laurel Bowie Road, Suite 301, Bowie, MD 20715 Ph: (301) 249-8838 |
News Archive
Until now, the mode of action of nitrogen-containing bisphosphonate (N-BP) cancer drugs, used to relieve bone pain and to prevent skeletal complications in bone metastasis, has been almost entirely unknown. Researchers writing in BioMed Central's open access journal Genome Biology have used 'barcoded' yeast mutants to identify new biological processes involved in the cellular response to N-BPs, opening up opportunities for the development of new anticancer drugs.
A three-judge panel in Atlanta will hear oral arguments in the lawsuit brought by 26 states. At issue is whether a Florida judge's ruling to strike down large portions of the sweeping overhaul should be reversed.
Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
› Verified 5 days ago
Dr. Amina T Watson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1700 Science Drive, Suite 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Toni Lynn Thompson-chittams, D.O Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4357 Northview Dr, Bowie, MD 20716 Phone: 301-352-6515 Fax: 301-352-6516 | |
Dr. Valorie Anlage, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 17001 Science Drive, Suite 116, Bowie, MD 20715 Phone: 301-464-2300 Fax: 301-776-8052 | |
Dr. Brenda Karen Pettus-bellamy, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd, Suite 301, Bowie, MD 20715 Phone: 301-249-8838 Fax: 301-249-5334 | |
Dr. Necole Elease Washington, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2905 Mitchellville Rd, Suite 108, Bowie, MD 20716 Phone: 301-218-0398 Fax: 301-218-0040 | |
Suzette Scipio - Ettienne, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2905 Mitchellville Rd, Ste 115, Bowie, MD 20716 Phone: 301-390-7960 Fax: 301-218-2800 |